Get startedLog in
    Picture of Yichang Hec Changjiang Pharmaceutical Co logo

    1558 — Yichang Hec Changjiang Pharmaceutical Co Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Yichang Hec Changjiang Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line2,2691,010-66739.42,127
    Depreciation
    Amortisation
    Non-Cash Items180-3082231,143788
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-741475-478140-1,633
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Other Operating Cash Flow
    Cash from Operating Activities1,7941,299-6631,7001,673
    Capital Expenditures-1,673-1,918-580-853-595
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-37.6-177141-2671,150
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-1,710-2,095-439-1,120555
    Financing Cash Flow Items-59.5-95.2-99.8-151-178
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities2,10064.6187-787-1,477
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash2,185-734-914-208751